Form 4: Invus Public Equities, L.P. Reduces Stake in GlycoMimetics Inc. (GLYC)

Invus Public Equities, L.P. reports selling shares of GlycoMimetics Inc. at weighted average prices of $0.1884 and $0.1828, reducing its holdings.

Summary

• Invus Public Equities, L.P. filed a Form 4 detailing changes in beneficial ownership of GlycoMimetics Inc. (GLYC) stock.
• On August 5, 2024, Invus Public Equities, L.P. sold 164,523 shares of common stock at a weighted average price of $0.1884 per share.
• The sales on August 5th occurred in multiple transactions with prices ranging from $0.187 to $0.1891 per share.
• On August 6, 2024, Invus Public Equities, L.P. sold 55,732 shares of common stock at a weighted average price of $0.1828 per share.
• The sales on August 6th occurred in multiple transactions with prices ranging from $0.18 to $0.1907 per share.
• Following these transactions, Invus Public Equities, L.P. directly holds 6,639,926 shares of GlycoMimetics Inc. common stock.
• Raymond Debbane signed the report on behalf of Invus Public Equities, L.P. and related entities.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a major shareholder reducing their position, which could indicate a lack of confidence or a need for liquidity. However, the document itself is just a factual report of transactions.

Negatives

• Invus Public Equities, L.P., a significant shareholder, is reducing its stake in GlycoMimetics Inc.

Risks

• Continued selling pressure from Invus Public Equities, L.P. could negatively impact the stock price.
• The reasons for the share sales are not disclosed, creating uncertainty for investors.

Industry Context

Form 4 filings are standard disclosures for significant shareholders and insiders, providing transparency into their trading activities. This sale could be part of a broader portfolio rebalancing strategy or reflect a change in outlook for GlycoMimetics.

Stakeholder Impact

• Shareholders may react negatively to the news of a major shareholder selling shares.
• The company may experience downward pressure on its stock price.

Key Dates